Theres golden-goose-2:native on @RobinhoodApp
Now there $BUG on @LaunchOnSF
Both paired with Gold stocks...
Gold Bug ($BUG)
MC: 23.5k
5ff6wtQeABBBzBqPBtJhHa5D58dT4L6hn6uetomNAJzY
You wanna be early on a potential giga sender? @aniuonRH is an Alibaba mascot. #RH memes paired with stocks have been flying, and #Alibaba has big events coming this month ;)
Check out $ANIU on fomo:
https://t.co/znOhaFqwBr
Grok Companions are leaving the Grok app and the team behind the 3D avatars has launched Animates, their new home.
0xdd46682391f537ffc4dc5b3bdd612637a764f762
NFA
Elite Elon Musk Narra.
The next major GLP-1 may not be a peptide—or an injection.
ASC30 activates the GLP-1 receptor, but it’s actually an oral small molecule.
Why that distinction matters? Read comments below
• Once-daily tablet
• No injection required
• ~4,600 Phase 3 participants
• Trials across Canada, the U.S. and Europe
• Three doses tested over 72 weeks
If the results hold up, the real breakthrough could be scalability and access—not simply greater weight loss.
@reptidesco Canada being included in this 4,600-participant Phase 3 program is worth watching.
If oral small-molecule GLP-1s can deliver competitive results without injections, refrigeration or complex peptide manufacturing, the real disruption could be access and scalability